BAG3-DCM Natural History Study

计划入组 30 人 · 首次发布于 2026 年 3 月 20 日

A Study About the Natural History in Adults With BAG3 Dilated Cardiomyopathy (a Type of Heart Disease) (BAG3 DCM)

计划入组 35 人 · 首次发布于 2023 年 8 月 8 日

A Phase 1 AAV Gene Therapy Trial Evaluating Safety and Preliminary Efficacy of RP-A701 in Subjects With BAG3 Dilated Cardiomyopathy

计划入组 8 人 · 首次发布于 2025 年 8 月 22 日

AAV-BAG3

DCM-205

PCMC1D3-DCM

LABORATORIOS BAGO S.A.

Argentina

ACM Research

United States

PHARMA DOM

France

Affinia Therapeutics Advances AFTX-201 for BAG3 Dilated Cardiomyopathy

Affinia Therapeutics Partners with DCM Foundation to Advance BAG3 Dilated Cardiomyopathy Awareness and Genetic Testing

Affinia Therapeutics Advances Novel Gene Therapy for BAG3 Dilated Cardiomyopathy with Promising Preclinical Results